The disclosure relates to an isolated strain of Lactobacillus crispatus, identified as IP174178 and deposited at the CNCM under number 1-464 or an isolated strain having the same characteristics as IP174178. The disclosure also relates to a pharmaceutical composition or a nutraceutical composition including such a strain, and to the use thereof for the treatment or prevention of genital infections.
